Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Antibody-based HIV-1 vaccines: recent developments and future directions.

Montefiori D, Sattentau Q, Flores J, Esparza J, Mascola J; Working Group convened by the Global HIV Vaccine Enterprise.

PLoS Med. 2007 Dec;4(12):e348. No abstract available.

2.

Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Montefiori DC.

Springer Semin Immunopathol. 1997;18(3):371-90. Review. No abstract available.

PMID:
9089955
3.

Serological responses to candidate AIDS vaccines.

Graham BS.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S145-8. Review. No abstract available.

PMID:
7865290
4.

New insights into protective humoral responses and HIV vaccines.

Stamatatos L, Davis D.

AIDS. 2001;15 Suppl 5:S105-15. Review. No abstract available.

PMID:
11816158
5.

B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.

Cagigi A, Nilsson A, De Milito A, Chiodi F.

Vaccine. 2008 Jun 6;26(24):3016-25. doi: 10.1016/j.vaccine.2007.11.063. Epub 2007 Dec 17. Review.

PMID:
18164520
6.

Epitope-vaccine as a new strategy against HIV-1 mutation.

Xiao Y, Lu Y, Chen YH.

Immunol Lett. 2001 May 1;77(1):3-6. Review.

PMID:
11348663
7.

HIV/AIDS vaccines: 2007.

Robinson HL.

Clin Pharmacol Ther. 2007 Dec;82(6):686-93. Epub 2007 Oct 31. Review.

PMID:
17971817
8.

The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.

Wyatt R, Sodroski J.

Science. 1998 Jun 19;280(5371):1884-8. Review.

PMID:
9632381
9.

Exploiting the defensive sugars of HIV-1 for drug and vaccine design.

Scanlan CN, Offer J, Zitzmann N, Dwek RA.

Nature. 2007 Apr 26;446(7139):1038-45. Review.

PMID:
17460665
10.

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.

Parren PW, Gauduin MC, Koup RA, Poignard P, Fisicaro P, Burton DR, Sattentau QJ.

Immunol Lett. 1997 Jun 1;57(1-3):105-12. Review. Corrected and republished in: Immunol Lett. 1997 Jul;58(2):125-32.

PMID:
9232434
11.

Humoral immunity to HIV, SIV, and SHIV.

Haigwood NL, Zolla-Pazner S.

AIDS. 1998;12 Suppl A:S121-32. Review. No abstract available.

PMID:
9632993
12.

[Anti-HIV-1 p17 antibody as anti-HIV agent].

Tsuchie H, Tochikura A, Kageyama S, Kurimura T.

Nihon Rinsho. 1993 Sep;51 Suppl:213-8. Review. Japanese. No abstract available.

PMID:
8271386
13.

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".

Parren PW, Gauduin MC, Koup RA, Poignard P, Sattentau QJ, Fisicaro P, Burton DR.

Immunol Lett. 1997 Jul;58(2):125-32. Review.

PMID:
9271324
14.

Enhancing antibodies in HIV infection.

Füst G.

Parasitology. 1997;115 Suppl:S127-40. Review.

PMID:
9571698
15.

Broadly neutralizing antibodies against HIV-1: templates for a vaccine.

van Gils MJ, Sanders RW.

Virology. 2013 Jan 5;435(1):46-56. doi: 10.1016/j.virol.2012.10.004. Review.

16.

Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.

Hone DM, DeVico AL, Fouts TR, Onyabe DY, Agwale SM, Wambebe CO, Blattner WA, Gallo RC, Lewis GK.

J Hum Virol. 2002 Jan-Feb;5(1):17-23. Review.

PMID:
12352264
17.

Vaccines and immunology. Recent advances in HIV/AIDS vaccine development.

Landay A, Heeney JL.

AIDS. 2001;15 Suppl 5:S101-3. Review. No abstract available.

PMID:
11816157
18.

Antibody polyspecificity and neutralization of HIV-1: a hypothesis.

Haynes BF, Moody MA, Verkoczy L, Kelsoe G, Alam SM.

Hum Antibodies. 2005;14(3-4):59-67. Review.

19.

Current progress in HIV vaccines.

Westblom TU, Belshe RB, Gorse GJ.

Mo Med. 1991 Nov;88(11):762-5. Review. No abstract available.

PMID:
1805131
20.

DNA gene vaccination for HIV.

Kim JJ, Weiner DB.

Springer Semin Immunopathol. 1997;19(2):175-94. Review. No abstract available.

PMID:
9406345

Supplemental Content

Support Center